4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-070255
Chairman and CEO bought 9,500 shares at an average $1.53 ($14,570)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-12-10 | Purchase | +1,000 | $1.57 | $1,570 | 11,097,806 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-14 | Purchase | +1,500 | $1.52 | $2,280 | 11,099,306 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-15 | Purchase | +3,000 | $1.52 | $4,560 | 11,102,306 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-16 | Purchase | +4,000 | $1.54 | $6,160 | 11,106,306 | D |
| Open-market purchases · 9,500 sh · avg $1.53 · $14,570 | |||||||
Loading xslF345X03/doc4.xml…